# Open Label Study Telmisartan and Amlodipine in Hypertension

> **NCT00614380** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 976 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** telmisartan/amlodipine 40/5 mg fixed combination
- **DRUG:** telmisartan/amlodipine 80/5 mg fixed combination

## Key facts

- **NCT ID:** NCT00614380
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-03
- **Final completion:** —
- **Target enrollment:** 976 (ACTUAL)
- **Last updated:** 2014-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614380, "Open Label Study Telmisartan and Amlodipine in Hypertension". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00614380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*